|

TRIFORMIS RESILIA Real-world Study Assessing Safety and Performance (TRIBLAZE Study)

RECRUITINGSponsored by Edwards Lifesciences
Actively Recruiting
SponsorEdwards Lifesciences
Started2026-09-22
Est. completion2030-08
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site

Summary

TRIBLAZE is a prospective, observational, single-arm, multicenter study designed to collect real-world clinical outcomes in a minimum of 75 participants who will receive the Edwards Lifesciences TRIFORMIS RESILIA surgical tricuspid heart valve, Model 11300T.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* 18 years or older
* Indication for TRIFORMIS valve implant for native or prosthetic valve dysfunction
* Provide written informed consent prior to the 30-day imaging follow-up
* Willing and able to return for scheduled follow-up visits

Exclusion Criteria:

• Untreatable hypersensitivity to nitinol alloys (nickel and titanium)

Conditions5

Cardiovascular DiseasesHeart DiseaseHeart DiseasesHeart Valve DiseasesTricuspid Valve Disease

Locations1 site

Ascension St. Vincent's Hospital
Carmel, Indiana, 46260
David Heimansohn, MD

Find trials near these locations

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.